| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Fulgent Genetics, Inc. (FLGT) has 4 insiders with recent SEC Form 4 filings, including 3 buys and 1 sell. FLGT is classified in the Life Sciences Tools & Services industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Other | 951.6K | $17.35M | - | |
| CEO | 897.7K | $16.36M | - | |
| COO | 332.0K | $6.05M | - | |
| CFO | 328.1K | $5.98M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Jun 13, 2017 | Hsieh Ming | President And CEO | Buy | 30,000 | $4.98 | $149,395.50 | +0.2% | |
| Sep 30, 2016 | Hsieh Ming | President And CEO | Buy | 1,000,000 | $9.00 | $9,000,000.00 | +18.4% | |
| May 13, 2016 | Gao Hanlin73 | Chief Scientific Officer | Sell | 2,565,789 | $1.17 | $2,994,019.18 | -16.0% |